TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 26 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,177,378 | -57.5% | 23,393,000 | -47.3% | 0.07% | -61.4% |
| Q2 2023 | $35,708,619 | +17.6% | 44,393,000 | +43.7% | 0.18% | +14.3% |
| Q1 2023 | $30,367,819 | -30.9% | 30,893,000 | -35.7% | 0.15% | -51.9% |
| Q4 2022 | $43,959,345 | +23.2% | 48,043,000 | +37.7% | 0.32% | +48.8% |
| Q3 2022 | $35,685,000 | +13.3% | 34,900,000 | +11.1% | 0.22% | +39.6% |
| Q2 2022 | $31,494,000 | +47.9% | 31,400,000 | +57.0% | 0.15% | +161.0% |
| Q1 2022 | $21,290,000 | – | 20,000,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 18,167 | $17,858 | 1.50% |
| BRAIDWELL LP | 28,350,000 | $27,868,050 | 0.92% |
| READYSTATE ASSET MANAGEMENT LP | 9,000,000 | $8,847,000 | 0.82% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,382,000 | $20,985 | 0.77% |
| UBS OCONNOR LLC | 20,000,000 | $19,700,500 | 0.60% |
| CSS LLC/IL | 8,178,000 | $8,038,680 | 0.53% |
| WOLVERINE ASSET MANAGEMENT LLC | 37,900,000 | $37,317,810 | 0.44% |
| Segantii Capital Management Ltd | 10,000,000 | $9,827,050 | 0.34% |
| LINDEN ADVISORS LP | 28,993,000 | $28,511,354 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 30,893,000 | $30,367,819 | 0.15% |